150
Views
4
CrossRef citations to date
0
Altmetric
Research Article

MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors

&
Pages 45-52 | Received 10 Sep 2009, Accepted 29 Apr 2010, Published online: 18 Oct 2010

References

  • Bassenge, E. (1996). Endothelial function in different organs. Prog Cardiovasc Dis 39:209–228.
  • Blenis, J. (1993). Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 90:5889–5892.
  • Chen, T. J., Jeng, J. Y., Lin, C. W., Wu, C. Y., Chen, Y. C. (2006). Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223:113–126.
  • Dasmahapatra, G., Rahmani, M., Dent, P., Grant, S. (2006). The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107:232–240.
  • Estrela, J. M., Ortega, A., Obrador, E. (2006). Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143–181.
  • Genestra, M. (2007). Oxyl radicals, redox-sensitive signalling cascades, and antioxidants. Cell Signal 19:1807–1819.
  • Gomez-Lazaro, M., Galindo, M. F., Melero-Fernandez de Mera, R. M., Fernandez-Gomez, F. J., Concannon, C. G., Segura, M. F., Comella, J. X., Prehn, J. H., Jordan, J. (2007). Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol Pharmacol 71:736–743.
  • Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., Holbrook, N. J. (1996). Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271:4138–4142.
  • Han, Y. H., Kim, S. H., Kim, S. Z., Park, W. H. (2008a). Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int J Oncol 33:1099–1105.
  • Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2007). Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am J Physiol Renal Physiol 293:F511–F520.
  • Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2008b). Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 59:301–314.
  • Henson, E. S., Gibson, S. B. (2006). Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 18:2089–2097.
  • Higuchi, Y. (2004). Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8:455–464.
  • Hsin, Y. H., Chen, C. F., Huang, S., Shih, T. S., Lai, P. S., Chueh, P. J. (2008). The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179:130–139.
  • Jahngen-Hodge, J., et al. (1997). Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272:28218–28226.
  • Kusuhara, M., et al. (1998). p38 kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res 83:824–831.
  • Lee, D. H., Goldberg, A. L. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8:397–403.
  • Ling, Y. H., Liebes, L., Zou, Y., Perez-Soler, R. (2003). Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small-cell lung cancer cells. J Biol Chem 278:33714–33723.
  • Mao, X., Yu, C. R., Li, W. H., Li, W. X. (2008). Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res 18:879–888.
  • Orlowski, R. Z. (1999). The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6:303–313.
  • Park, W. H., et al. (2000). Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60:3065–3071.
  • Perez-Galan, P., Roue, G., Villamor, N., Montserrat, E., Campo, E., Colomer, D. (2006). The proteasome inhibitor, bortezomib, induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107:257–264.
  • Qiu, J. H., Asai, A., Chi, S., Saito, N., Hamada, H., Kirino, T. (2000). Proteasome inhibitors induce cytochrome c-caspase-3–like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 20:259–265.
  • Rygiel, T. P., Mertens, A. E., Strumane, K., van der Kammen, R., Collard, J. G. (2008). The Rac activator, Tiam1, prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 121:1183–1192.
  • Voges, D., Zwickl, P., Baumeister, W. (1999). The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015–1068.
  • Wu, H. M., Chi, K. H., Lin, W. W. (2002). Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. FEBS Lett 526:101–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.